Latest Deadline: 30 August 2019

  • Call for abstracts

    Abstract submission is now open

    The GG2020 Conference Scientific Committee invites you to submit abstracts of poster presentation. Deadline for abstract submission is 1 September 2019.


Welcome Message

Dear Colleagues,

Greetings from the Organizing Committee of the Conference on Global Globin 2020 Challenge (GG2020 Conference 2019).

On behalf of the local organizing committee, we are pleased to invite you to participate in the Conference on Global Globin conference to be held from October 28 (Monday) - October 30 (Wednesday), 2019 at the UNESCO, Paris.

The theme of the conference is "Enhancing Partnership Towards Equitable Healthcare", focusing on a wide range of topics from variant detection to advanced human genomic data sharing. The scientific committee is planning a stimulating academic program including plenary lectures, symposia and poster presentations to keep you updated on how to implement the latest development in human genomic which involves data accumulation and sharing systematically to avert hemoglobin/blood diseases especially Thalassemia and Sickle Cell Disease (SCD). The organizing committee is looking forward to the participation of everyone from every country and region of the world.

We very much look forward to welcoming you in Paris this October.

Prof. Zilfalil Alwi
Chair, Organizing Committee,
GG2020 Conference

~Explore GG2020 Conference~

The GG2020 Conference Committee invites you to participate in this conference as presenter or non-presenter

Register Now

About Conference

Global Globin 2020 Challenge (GG2020) seeks to apply recent developments in human genomics involving the systematic collection and sharing of variation data to fighting haemoglobinopathies (notably thalassaemias and sickle cell disease) in low- and middle-income countries. GG2020 has focussed on bringing together current knowledge and information concerning various haemoglobinopathies in all parts of the world, with a focus on sickle cell disease (SCD) and thalassaemia.